Neuraminidase Mutations Conferring Resistance to Oseltamivir in Influenza A(H7N9) Viruses

Journal of Virology
Henju MarjukiLarisa V Gubareva

Abstract

Human infections by avian influenza A(H7N9) virus entail substantial morbidity and mortality. Treatment of infected patients with the neuraminidase (NA) inhibitor oseltamivir was associated with emergence of viruses carrying NA substitutions. In the NA inhibition (NI) assay, R292K conferred highly reduced inhibition by oseltamivir, while E119V and I222K each caused reduced inhibition. To facilitate establishment of laboratory correlates of clinically relevant resistance, experiments were conducted in ferrets infected with virus carrying wild-type or variant NA genes recovered from the A/Taiwan/1/2013 isolate. Oseltamivir treatment (5 or 25 mg/kg of body weight/dose) was given 4 h postinfection, followed by twice-daily treatment for 5 days. Treatment of ferrets infected with wild-type virus resulted in a modest dose-dependent reduction (0.7 to 1.5 log10 50% tissue culture infectious dose [TCID50]) in nasal wash viral titers and inflammation response. Conversely, treatment failed to significantly inhibit the replication of R292K or E119V virus. A small reduction of viral titers was detected on day 5 in ferrets infected with the I222K virus. The propensity for oseltamivir resistance emergence was assessed in oseltamivir-treated an...Continue Reading

References

Feb 15, 2001·The Journal of Infectious Diseases·L V GubarevaF G Hayden
Oct 1, 2004·Lab Animal·John A Maher, Joanne DeStefano
Feb 15, 2005·The Journal of Antimicrobial Chemotherapy·Penelope WardRegina Dutkowski
Oct 18, 2005·Nature·Q Mai LeYoshihiro Kawaoka
Apr 28, 2006·Antimicrobial Agents and Chemotherapy·Aeron C HurtJennifer L McKimm-Breschkin
Feb 14, 2007·Antimicrobial Agents and Chemotherapy·Elena A GovorkovaRobert G Webster
Dec 7, 2007·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·Olivier Ferraris, Bruno Lina
Jul 22, 2009·The Journal of Infection·Naoki KawaiSeizaburo Kashiwagi
Aug 4, 2011·Disease Models & Mechanisms·Jessica A BelserTerrence M Tumpey
Dec 24, 2011·Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy·Naoki KawaiSeizaburo Kashiwagi
Feb 9, 2012·Antiviral Therapy·Ha T NguyenLarisa V Gubareva
Apr 13, 2013·The New England Journal of Medicine·Rongbao GaoYuelong Shu
May 4, 2013·Lancet·Sui-Yuan ChangShan-Chwen Chang
Jul 3, 2013·Lancet·Alan J Hay, Frederick G Hayden
Jul 12, 2013·Nature·Tokiko WatanabeYoshihiro Kawaoka
Aug 24, 2013·Emerging Infectious Diseases·Katrina SleemanLarisa V Gubareva
Oct 1, 2013·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Pi-Han LinPan-Chyr Yang
Jun 22, 2014·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Yan-rong WangXian-feng Wang
Aug 16, 2014·The Journal of Infectious Diseases·Henju MarjukiLarisa V Gubareva
Jan 13, 2015·Saudi Journal of Kidney Diseases and Transplantation : an Official Publication of the Saudi Center for Organ Transplantation, Saudi Arabia·Somsri Wiwanitkit, Viroj Wiwanitkit

❮ Previous
Next ❯

Citations

Feb 13, 2016·Frontiers in Microbiology·Ding Y Oh, Aeron C Hurt
Sep 22, 2015·Viruses·Timothy C M LiNelson Lee
Jan 10, 2016·Journal of Molecular Biology·Angela M Phillips, Matthew D Shoulders
Dec 15, 2015·Journal of Molecular Biology·Li JiangDaniel N A Bolon
Oct 21, 2015·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Xiao-Xin WuLan-Juan Li
Sep 30, 2015·The Journal of Infectious Diseases·Andy KilianskiKayvon Modjarrad
Sep 10, 2016·Avian Diseases·Agnes AgunosNathaniel Tablante
Apr 25, 2018·The Journal of Infectious Diseases·Xiaohui ZouUNKNOWN community-acquired pneumonia-China Network
Jun 10, 2015·Antimicrobial Agents and Chemotherapy·Yasushi ItohKazumasa Ogasawara
Oct 5, 2018·Journal of Virology·Elizabeth J FayRyan A Langlois
Jun 13, 2019·Influenza and Other Respiratory Viruses·Erin N HodgesLarisa V Gubareva
Sep 22, 2019·The Journal of Infectious Diseases·Anton ChesnokovLarisa V Gubareva
Apr 8, 2020·Journal of Cellular and Molecular Medicine·Yong-Bin ChoYoung-Jin Seo
Jan 29, 2020·Frontiers of Medicine·Xiaoxin WuLanjuan Li
Sep 16, 2018·Viruses·Ahmed MostafaStephan Pleschka
Dec 18, 2020·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Wei ChengYe Shen
Jul 6, 2021·Frontiers in Pediatrics·Cecilia PerretJose A Castro-Rodriguez
Mar 25, 2020·Cold Spring Harbor Perspectives in Medicine·Chengjun Li, Hualan Chen

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.